Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; no visible changes to study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/operating status notice was removed from the page. No clinical trial details or study information were changed.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant differences in the core Study Details page (NCT03143036) between the two screenshots; the study information appears unchanged aside from minor formatting. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update to page content with new government status notice and NIH Clinical Center operating status, plus version bump to v3.2.0; removal of a specific genetic disease resource (Multiple myeloma) and downgrade from v3.1.0 to v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedCore term updated from Plasma cell myeloma to Multiple myeloma; new version v3.1.0; added identifier/phone-like number 6779 5555.SummaryDifference0.2%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, which is a minor UI change; no other substantive content changes were detected.SummaryDifference0.2%

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.